Shockwave Medical Inc (SWAV)
330.58
-0.02
(-0.01%)
USD |
NASDAQ |
May 10, 15:31
Shockwave Medical Enterprise Value: 12.12B for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 12.12B |
| May 08, 2024 | 12.12B |
| May 07, 2024 | 12.11B |
| May 06, 2024 | 12.09B |
| May 03, 2024 | 12.11B |
| May 02, 2024 | 12.09B |
| May 01, 2024 | 12.09B |
| April 30, 2024 | 12.09B |
| April 29, 2024 | 12.06B |
| April 26, 2024 | 12.08B |
| April 25, 2024 | 12.04B |
| April 24, 2024 | 12.04B |
| April 23, 2024 | 12.03B |
| April 22, 2024 | 12.03B |
| April 19, 2024 | 12.04B |
| April 18, 2024 | 11.99B |
| April 17, 2024 | 11.99B |
| April 16, 2024 | 11.99B |
| April 15, 2024 | 11.97B |
| April 12, 2024 | 11.99B |
| April 11, 2024 | 12.01B |
| April 10, 2024 | 12.07B |
| April 09, 2024 | 11.98B |
| April 08, 2024 | 11.92B |
| April 05, 2024 | 11.94B |
| Date | Value |
|---|---|
| April 04, 2024 | 11.71B |
| April 03, 2024 | 11.73B |
| April 02, 2024 | 11.70B |
| April 01, 2024 | 11.73B |
| March 31, 2024 | 11.92B |
| March 28, 2024 | 11.92B |
| March 27, 2024 | 11.81B |
| March 26, 2024 | 11.56B |
| March 25, 2024 | 10.48B |
| March 22, 2024 | 10.25B |
| March 21, 2024 | 10.41B |
| March 20, 2024 | 10.42B |
| March 19, 2024 | 10.18B |
| March 18, 2024 | 10.10B |
| March 15, 2024 | 9.988B |
| March 14, 2024 | 9.698B |
| March 13, 2024 | 9.815B |
| March 12, 2024 | 9.640B |
| March 11, 2024 | 9.380B |
| March 08, 2024 | 9.154B |
| March 07, 2024 | 9.319B |
| March 06, 2024 | 9.269B |
| March 05, 2024 | 9.158B |
| March 04, 2024 | 9.483B |
| March 01, 2024 | 9.592B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
554.16M
Minimum
Mar 20 2020
12.12B
Maximum
May 08 2024
5.423B
Average
6.098B
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 117.47B |
| AtriCure Inc | 1.022B |
| Masimo Corp | 7.315B |
| Perspective Therapeutics Inc | 1.049B |
| Xtant Medical Holdings Inc | 121.55M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 55.35M |
| Revenue (Quarterly) | 218.80M |
| Total Expenses (Quarterly) | 176.40M |
| EPS Diluted (Quarterly) | 1.44 |
| Gross Profit Margin (Quarterly) | 87.11% |
| Profit Margin (Quarterly) | 25.29% |
| Earnings Yield | 1.29% |
| Operating Earnings Yield | 1.28% |
| Normalized Earnings Yield | 1.295 |